By Tom Zanki ( September 11, 2023, 4:12 PM EDT) -- Brain disease-focused Neumora Therapeutics Inc. and radiopharmaceutical-drug maker RayzeBio Inc. launched plans on Monday for initial public offerings that could raise a combined $495 million under the guidance of three law firms, hoping to benefit from a recovering IPO market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.